Bladder Cancer

@BladderCaJrnl

BLC Journal | Dedicated to expediting our understanding & improving treatments of bladder and upper urinary tract cancers | Editors Seth Lerner, Dan Theodorescu

Worldwide
Joined May 2015

Tweets

You blocked @BladderCaJrnl

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @BladderCaJrnl

  1. Retweeted
    Aug 10

    Looking to hire my first postdoc. good sci temperament and skill in Tcell culture would be great, informatics interest huge bonus. DM me!

  2. Retweeted
    Aug 1

    Checked out the new ? Great content, led by the Mulders & ! Check out the inaugural issue!

    , , and 5 others
  3. Retweeted
    Aug 11
  4. Retweeted
    Aug 5

    Dr. Jonathan Rosenberg discusses antibody drug conjugates in

  5. Retweeted
    Aug 5

    But as we close the NMIBC session- there is hope.

  6. Aug 5

    Peter O'Donnell: immunotherapy tidal wave runs risk of forgetting about targeted therapies. Opportunity but TKI is big. It works!

  7. Aug 5

    Rosenberg: antibody-drug conjugates work. Relief of bone pain and some dramatic responses.

  8. Retweeted
    Aug 5

    Very interesting discussion around new NMIBC treatment approaches. Great session!

  9. Aug 4

    Palmbos: ATDC expression associates with basal subtype signature and basal subtype markers. Activated by p63, a basal marker.

  10. Aug 4

    Palmbos: ATDC overexpressing mice get bladder cancer, and ATDC knockdown cripples cells

  11. Aug 4

    Lerner: TCGA update new driver genes, mutation processes, hypotheses regarding subtype-specific treatment

  12. Aug 4

    Save the dates! BCAN events 2017. Contact

  13. Retweeted
    Aug 4

    Kohn: the predictive biomarker cookbook in urothelial cancer.

  14. Aug 4

    Elise Kohn simplifies predictive/prognostic biomarkers

  15. Aug 4

    wow, phase III chemoradiotherapy +/- atezo trial for bladder preservation.

  16. Aug 4

    Kent Mouw: chemoradiotherapy response associated with luminal infiltrated gene signature.

  17. Aug 4

    Karim Chamie: 7% of pts w/ MIBC get the standard of care (neoadjuvant + RC in NCDB); 28% RC alone. Have to do better.

  18. Aug 4

    U of Utah vasc surgeon Patient report outcomes on IPad in <4 minutes. Incorporated into EMR. Could adapt.

  19. Retweeted
    Aug 1

    Getting ready for by reading The Startling History Behind Merck's New Cancer Blockbuster

  20. Aug 3

    in Charlotte!

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·